西山 博之(ニシヤマ ヒロユキ)
- 論文
- FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression
Sternberg Cora N; Petrylak Daniel P; Bellmunt Joaquim; ...
Journal of clinical oncology : official journal of the American Society of Clinical Oncology/41(3)/pp.629-639, 2023-01-20 - Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi‑institutional retrospective study
Kato Renpei; Naito Sei; Numakura Kazuyuki; Hatakeyama ...
International journal of clinical oncology/28(5)/pp.726-727, 2023-05-01 - Subsequent Upper Urinary Tract Carcinoma Related to Worse Survival in Patients Treated with BCG
Numakura Kazuyuki; Miyake Makito; Kobayashi Mizuki; Mu...
Cancers/15(7), 2023-03-28 - Subsequent Upper Urinary Tract Carcinoma Related to Worse Survival in Patients Treated with BCG
Numakura Kazuyuki; Miyake Makito; Kobayashi Mizuki; Muto ...
CANCERS/15(7), 2023-03-28 - Discontinuation of pembrolizumab for advanced urothelial carcinoma without disease progression: Nationwide cohort study
Ito Katsuhiro; Kita Yuki; Yokomizo Akira; Miki Jun; Y...
CANCER MEDICINE/Epub, 2022-07 - Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1
Harada Miyuki; Kimura Fuminori; Takai Yasushi; Nakajima ...
International Journal of Clinical Oncology/27(2)/pp.265-280, 2022-02 - Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study
Kato Renpei; Naito Sei; Numakura Kazuyuki; Hatakeyama ...
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/27(3)/pp.563-573, 2022-03 - Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study)
Kobayashi Keita; Matsuyama Hideyasu; Kawai Taketo; Ikeda ...
INTERNATIONAL JOURNAL OF UROLOGY/29(7)/pp.632-638, 2022-07 - Association of Increased Age With Decreased Response to Intravesical Instillation of Bacille Calmette-Guérin in Patients With High-Risk Non-Muscle Invasive Bladder Cancer: Retrospective Multi-Institute Results From the Japanese Urological Oncology Research Group JUOG-UC-1901-BCG
Inoue Takamitsu; Miyake Makito; Nishimura Nobutaka; On...
UROLOGY/167/pp.158-164, 2022-09-01 - Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guerin failure in non-muscle-invasive bladder cancer
Murakami Yasukiyo; Matsumoto Kazumasa; Miyake Makito; ...
INTERNATIONAL JOURNAL OF UROLOGY/29(10)/pp.1195-1203, 2022-10 - Cancer-specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapy
Narita Shintaro; Terada Naoki; Nomura Kyoko; Sakamoto ...
INTERNATIONAL JOURNAL OF UROLOGY/29(10)/pp.1147-1154, 2022-10 - Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guerin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data
Tomida Ryotaro; Miyake Makito; Minato Ryoei; Sawada Yuic...
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/27(5)/pp.958-968, 2022-05 - Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis
Kobayashi Mizuki; Narita Shintaro; Matsui Yoshiyuki; K...
BJU INTERNATIONAL/Epub, 2021-06 - Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR
Kobayashi Takashi; Ito Katsuhiro; Kojima Takahiro; Mar...
CANCER IMMUNOLOGY IMMUNOTHERAPY/Epub, 2021-07 - Clinical practice pattern in patients with advanced urothelial cancer who had progressed on pembrolizumab in the pre-enfortumab vedotin era
Kita Yuki; Ito Katsuhiro; Sano Tomoyasu; Hashimoto Ko...
INTERNATIONAL JOURNAL OF UROLOGY/29(7)/pp.647-655, 2022-07 - Plasma circulating tumor DNA profiling in patients with chemo-refractory germ cell tumors
Sakka Shotaro; Kandori Shuya; Kawai Koji; Kojima Taka...
International journal of urology : official journal of the Japanese Urological Association, 2023-02-06 - Guidance on the need for contraception related to use of pharmaceuticals: the Japan Agency for Medical Research and Development Study Group for providing information on the proper use of pharmaceuticals in patients with reproductive potential
Suzuki Nao; Takai Yasushi; Yonemura Masahito; Negoro ...
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/27(5)/pp.829-839, 2022-05 - Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matching
Nishiyama Naotaka; Kobayashi Takashi; Narita Shintaro; Hi...
JOURNAL OF GERIATRIC ONCOLOGY/13(1)/pp.88-93, 2022-01 - Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinoma
Taoka Rikiya; Kobayashi Takashi; Hidaka Yu; Abe Hiroy...
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS/40(3), 2022-03 - Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2
Tozawa Akiko; Kimura Fuminori; Takai Yasushi; Nakajima T...
International Journal of Clinical Oncology/27(2)/pp.281-300, 2022-02 - Effects of antioxidant co-supplementation therapy on spermatogenesis dysfunction in relation to the basal oxidation-reduction potential levels in spermatozoa: A pilot study
Yamasaki Kazumitsu; Uchida Masahiro; Watanabe Noriko; ...
REPRODUCTIVE MEDICINE AND BIOLOGY/21(1), 2022-01 - The possible effects of the Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 on the practice of fertility preservation in female cancer patients in Japan
Kunitomi Chisato; Harada Miyuki; Sanada Yuko; Kusamoto...
REPRODUCTIVE MEDICINE AND BIOLOGY/21(1), 2022-01 - [Ⅲ. The 2022 Update of Pharmacotherapy for Renal Cell Carcinoma in Clinical Guidelines]
Kandori Shuya; Nishiyama Hiroyuki
Gan to kagaku ryoho. Cancer & chemotherapy/50(1)/pp.50-54, 2023-01-01 - Tolerability and treatment outcome of pembrolizumab in patients with advanced urothelial carcinoma and severe renal dysfunction
Kita Yuki; Ito Katsuhiro; Kanda Sohei; Joraku Akira; ...
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS/40(9), 2022-09 - Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo-refractory germ cell tumors
Kawahara Takashi; Kawai Koji; Kojima Takahiro; Nagumo ...
INTERNATIONAL JOURNAL OF UROLOGY/29(7)/pp.741-747, 2022-07-01 - さらに表示...
- FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression